These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34660334)

  • 21. Low and high-dose intradermal infection with Leishmania major and Leishmania amazonensis in C57BL/6 mice.
    Côrtes DF; Carneiro MB; Santos LM; Souza TC; Maioli TU; Duz AL; Ramos-Jorge ML; Afonso LC; Carneiro C; Vieira LQ
    Mem Inst Oswaldo Cruz; 2010 Sep; 105(6):736-45. PubMed ID: 20944986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential immune response modulation in early Leishmania amazonensis infection of BALB/c and C57BL/6 macrophages based on transcriptome profiles.
    Aoki JI; Muxel SM; Zampieri RA; Müller KE; Nerland AH; Floeter-Winter LM
    Sci Rep; 2019 Dec; 9(1):19841. PubMed ID: 31882833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine macrophages do not support the proliferation of Leishmania (Viannia) braziliensis amastigotes even in absence of nitric oxide and presence of high arginase activity.
    Teixeira MV; Soares SAE; Souza VA; de Souza Marques AM; de Almeida Soares CM; Baeza LC; de Oliveira MAP
    Parasitol Res; 2022 Oct; 121(10):2891-2899. PubMed ID: 35939146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell hypo-responsiveness against Leishmania major in MAP kinase phosphatase (MKP) 2 deficient C57BL/6 mice does not alter the healer disease phenotype.
    Schroeder J; McGachy HA; Woods S; Plevin R; Alexander J
    PLoS Negl Trop Dis; 2013; 7(2):e2064. PubMed ID: 23437409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
    von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
    Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory lesion and parasite load are inversely associated in Leishmania amazonensis infected mice genetically selected according to oral tolerance susceptibility.
    Tavares D; da Conceição Ribeiro R; Carlos da Silva A
    Microbes Infect; 2006 Apr; 8(4):957-64. PubMed ID: 16516520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis.
    Padigel UM; Alexander J; Farrell JP
    J Immunol; 2003 Oct; 171(7):3705-10. PubMed ID: 14500669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin--than on footpad-infected mice.
    Felizardo TC; Gaspar-Elsas MI; Lima GM; Abrahamsohn IA
    Exp Parasitol; 2012 Jan; 130(1):48-57. PubMed ID: 22019418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of interleukin-4 and prostaglandin E2 in Leishmania amazonensis infection of BALB/c mice.
    Guimarães ET; Santos LA; Ribeiro dos Santos R; Teixeira MM; dos Santos WL; Soares MB
    Microbes Infect; 2006 Apr; 8(5):1219-26. PubMed ID: 16531090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
    Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
    Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
    Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
    Front Immunol; 2018; 9():79. PubMed ID: 29459858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice.
    Almeida RP; Barral-Netto M; De Jesus AM; De Freitas LA; Carvalho EM; Barral A
    Am J Trop Med Hyg; 1996 Feb; 54(2):178-84. PubMed ID: 8619444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection.
    Wanasen N; Xin L; Soong L
    Int J Parasitol; 2008 Mar; 38(3-4):417-29. PubMed ID: 17959178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteopontin in the host response to Leishmania amazonensis.
    Giraud E; Rouault E; Fiette L; Colle JH; Smirlis D; Melanitou E
    BMC Microbiol; 2019 Feb; 19(1):32. PubMed ID: 30736736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential Regulation of l-Arginine Metabolism through Arginase 1 during Infection with Leishmania mexicana Isolates Obtained from Patients with Localized and Diffuse Cutaneous Leishmaniasis.
    Wilkins-Rodríguez AA; Pérez-Torres A; Escalona-Montaño AR; Gutiérrez-Kobeh L
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32312763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with
    Hu S; Marshall C; Darby J; Wei W; Lyons AB; Körner H
    Front Immunol; 2018; 9():1. PubMed ID: 29403488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corrigendum: Murine Susceptibility to
    Tomiotto-Pellissier F; Miranda-Sapla MM; Silva TF; Bortoleti BTDS; Gonçalves MD; Concato VM; Rodrigues ACJ; Detoni MB; Staurengo-Ferrari L; Verri WA; Costa IN; Panis C; Conchon-Costa I; Bordignon J; Pavanelli WR
    Front Cell Infect Microbiol; 2021; 11():804809. PubMed ID: 35282594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arginase I induction during Leishmania major infection mediates the development of disease.
    Iniesta V; Carcelén J; Molano I; Peixoto PM; Redondo E; Parra P; Mangas M; Monroy I; Campo ML; Nieto CG; Corraliza I
    Infect Immun; 2005 Sep; 73(9):6085-90. PubMed ID: 16113329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of negative air ions (NAIs) on Leishmania major: A novel tool for treatment of zoonotic cutaneous leishmaniasis (ZCL).
    Badirzadeh A; Najm M; Hemphill A; Alipour M; Hasanpour H; Masoori L; Karimi P
    PLoS One; 2022; 17(9):e0274124. PubMed ID: 36074764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.